Compare
Baiya International Group Inc. vs Syra Health Corp vs GEE Group Inc.
| Latest fiscal year | Baiya International Group Inc. BIYA | Syra Health Corp SYRA | GEE Group Inc. JOB |
|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-09-30 |
| Revenue | $16.48M | $7.23M | $96.50M |
| Revenue growth (YoY) | +28.6% | -9.5% | -9.8% |
| Gross margin | 11.5% | 34.4% | 34.6% |
| Operating margin | -58.1% | -12.5% | -26.2% |
| Net margin | -57.8% | -12.4% | -36.0% |
| Net income | -$9.53M | -$896.3K | -$34.75M |
| EPS (Diluted) | -$5.04 | -$0.08 | -$0.32 |
| Operating cash flow | -$7.44M | -$447.7K | $549.0K |
| Free cash flow | -$7.44M | -$447.9K | $533.0K |
| Cash & equivalents | $688.9K | $1.61M | n/a |
| Total assets | $27.83M | $2.77M | $60.00M |
| Total liabilities | $4.76M | $674.7K | $9.99M |
| Shareholders' equity | $23.07M | $2.10M | $50.01M |
| Return on year-end equity | -41.3% | -42.7% | -69.5% |
| Shares outstanding | n/a | n/a | 109.41M |
Revenue, most recent five fiscal years
| Fiscal year | Baiya International Group Inc. | Syra Health Corp | GEE Group Inc. |
|---|---|---|---|
| Latest | $16.48M Ended 2025-12-31 | $7.23M Ended 2025-12-31 | $96.50M Ended 2025-09-30 |
| 1 year earlier | $12.81M Ended 2024-12-31 | $7.98M Ended 2024-12-31 | $106.94M Ended 2024-09-30 |
| 2 years earlier | $11.57M Ended 2023-12-31 | $5.52M Ended 2023-12-31 | $152.44M Ended 2023-09-30 |
| 3 years earlier | $13.16M Ended 2022-12-31 | $5.62M Ended 2022-12-31 | $165.11M Ended 2022-09-30 |
| 4 years earlier | n/a | n/a | $148.88M Ended 2021-09-30 |